Estimated ORs and 95% CIs from multivariate models of diabetes care and outcomes
| HbA1c >9%†‡§ | No HbA1c laboratory test in 2011 | LDL≥100† | No LDL laboratory test in 2011 | SBP≥130† | No SBP reading in 2011 | Diabetes drug adherence ≥80%¶‡ | |
|---|---|---|---|---|---|---|---|
| American Indian/Alaska Native (reference: non-Hispanic Caucasian) | 1.41*** (1.31 to 1.51) | 0.96 (0.90 to 1.03) | 1.03 (0.99 to 1.08) | 1.01 (0.94 to 1.08) | 1.03 (0.99 to 1.06) | 0.92 (0.83 to 1.02) | 0.90*** (0.88 to 0.93) |
All models control for patient age and gender, geocoded Census Block Group income and education, HMO site, duration of diabetes, and comorbidities using the Quan Modified Elixhauser Comorbidity Scale.
*Statistically significant at p<0.05, **p<0.01, ***p<0.001.
†Restricted to patients with a measurement in year 2011.
‡Model controls for whether patient had a dispensing of insulin in year 2011.
§Model controls for whether patient had a dispensing of an oral diabetes medication in year 2011.
¶Restricted to patients with drug coverage who had two or more dispensings of an oral diabetes medication in the same drug class in year 2011.
LDL, low-density lipoprotein; HbA1c, glycated haemoglobin; SBP, systolic blood pressure.